Hepatic microvasculature in liver injury

Seminars in Liver Disease

Volumn 27, Issue 4, 2007, Pages 390-400

  DeLeve, Laurie D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Endothelial cell; Liver circulation; Liver fibrosis; Reperfusion injury; Toxic hepatitis; Veno occlusive disease

Indexed keywords

ANABOLIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; F ACTIN; GELATINASE A; GELATINASE B; GEMTUZUMAB OZOGAMICIN; GLUCOCORTICOID; INDUCIBLE NITRIC OXIDE SYNTHASE; METHOTREXATE; MITHRAMYCIN; MONOCROTALINE; NITRIC OXIDE; ORAL CONTRACEPTIVE AGENT; OXALIPLATIN; PARACETAMOL; RETINOL; SCAVENGER; THORIUM DIOXIDE; TIOGUANINE; URETHAN;

ARTICLE; CAPILLARY; CELL HYPOXIA; CLINICAL FEATURE; ENDOTHELIUM CELL; HUMAN; LIVER CIRCULATION; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER HYPERPLASIA; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LIVER SINUSOID; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; LUNG TOXICITY; MOUSE; NODULAR REGENERATIVE HYPERPLASIA; NONHUMAN; PELIOSIS HEPATIS; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; SINUSOIDAL DILATATION;

ANIMALS; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER DISEASES;

EID: 35948931882     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-991515     Document Type: Article

References (128)

1. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology 1963;44:239-242
2. Horn T, Christoffersen P, Henriksen JH. Alcoholic liver injury: defenestration in noncirrhotic livers - a scanning electron microscopic study. Hepatology 1987;7:77-82
3. Mori T, Okanoue T, Sawa Y, Hori N, Ohta M, Kagawa K. Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology 1993;17:891-897
4. Le Couteur DG, Cogger VC, Markus AM, et al. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001;33:537-543
5. McLean AJ, Cogger VC, Chong GC, et al. Age-related pseudocapillarization of the human liver. J Pathol 2003;200:112-117
6. Módis L, Martinez-Hernandez A. Hepatocytes modulate the hepatic microvascular phenotype. Lab Invest 1991;65:661-670
7. DeLeve LD, Wang X, Hu L, McCuskey MK, McCuskey RS. Rat liver sinusoidal endothelial cell phenotype is under paracrine and autocrine control. Am J Physiol Gastrointest Liver Physiol 2004;287:G757-G763
8. DeLeve LD, Wang X, Guo Y, Stolz A. Capillarization is due to the loss of paracrine and autocrine control of the sinusoidal endothelial cell (SEC) phenotype. Hepatology 2005;42:266A
9. Horn T, Junge J, Christoffersen P. Early alcoholic liver injury: changes of the Disse space in acinar zone 3. Liver 1985;5:301-310
10. Mori T, Okanoue T, Kanaoka H, Sawa Y, Kashima K. Experimental study of the reversibility of sinusoidal capillarization. Alcohol Alcohol 1994;29(suppl 1):67-74
11. DeLeve LD, Wang X, Guo Y. Differentiated but not capillarized sinusoidal endothelial cells prevent transdifferentiation of stellate cells and promote reversion of myofibroblasts (MFB) to stellate cells (HSC) in vitro. Hepatology 2006;44:687A
12. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037-2048
13. Hickey PL, Angus PW, McLean AJ, Morgan DJ. Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats. Gastroenterology 1995;108:1504-1509
14. Le Couteur DG, Hickey H, Harvey PJ, Gready J, McLean AJ. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. J Pharmacol Exp Ther 1999; 289:1553-1558
15. Froomes PRA, Morgan DJ, Smallwood RA, Angus PW. Comparative effects of oxygen supplementation on theophylline and acetaminophen clearance in human cirrhosis. Gastroenterology 1999;116:915-920
16. Redgrave TG. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest 1970;49:465-471
17. Wisse E. An electron microscopic study of the fenestrated endothelial lining of the rat liver sinusoids. J Ultrastruct Res 1970;31:125-150
18. Naito M, Wisse E. Filtration effect of endothelial fenestrations on chylomicron transport in neonatal rat liver sinusoids. Cell Tissue Res 1978;190:371-382
19. Fraser R, Bosanquet AG, Day WA. Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis. Atherosclerosis 1978;29:113-123
20. Wisse E, De Zanger RB, Charels K, van der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestra, the sinusoidal wall and the space of Disse. Hepatology 1985;5:683-692
21. Le Couteur DG, Fraser R, Cogger VC, McLean AJ. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 2002;359:1612-1615
22. Fraser R, Dobbs BR, Rogers GW. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 1995;21:863-874
23. Steinberg P, Lafranconi WM, Wolf CR, Waxman DJ, Oesch F, Friedberg T. Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver. Mol Pharmacol 1987;32:463-470
24. Steinberg P, Schlemper B, Molitor E, Platt KL, Seidel A, Oesch F. Rat liver endothelial and Kupffer cell-mediated mutagenicity of polycyclic aromatic hydrocarbons and aflatoxin B1. Environ Health Perspect 1990;88:71-76
25. DeLeve LD. Dacarbazine toxicity in murine liver cells: a novel model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther 1994;268:1261-1270
26. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-797
27. Haboubi NY, Ali HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988;83:256-261
28. Zafrani ES, Cazier A, Baudelot AM, Feldmann G. Ultrastructural lesions of the liver in human peliosis. A report of 12 cases. Am J Pathol 1984;114:349-359
29. DeLeve LD. Cancer chemotherapy. In: Kaplowitz N, DeLeve LD, eds. Drug-induced Liver Disease. 2nd ed. New York: Informa Healthcare; 2007:631-666
30. Arotcarena R, Cales V, Berthelemy P, et al. Severe sinusoidal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenterol Clin Biol 2006;30:1313-1316
31. Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases [comment]. J Am Coll Surg 2006;202:199-200
32. Bras G, Jeliffe DB, Stuart KL. Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica. Arch Pathol 1954;57:285-300
33. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994;19:1171-1180
34. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venoocclusive disease). Semin Liver Dis 2002;22:27-41
35. Eisenhauer T, Hartmann H, Rumpf KW, Helmchen U, Scheler F, Creutzfeldt W. Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature. Digestion 1984;30:185-190
36. Katzka DA, Saul SH, Jorkasky D, Sigal H, Reynolds JC, Soloway RD. Azathioprine and hepatic venocclusive disease in renal transplant patients. Gastroenterology 1986;90:446-454
37. Read AE, Wiesner RH, LaBrecque DR, et al. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. Ann Intern Med 1986;104:651-655
38. Liano F, Moreno A, Matesanz R, et al. Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause? [see comments]. Nephron 1989;51:509-516
39. Sterneck M, Wiesner R, Ascher N, et al. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991;14:806-810
40. Giles FJ, Kantarjian HM, Kornblau SM, et al. Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation. Cancer 2001;92:406-413
41. Rajvanshi P, Shulman HM, Sievers EL, McDonald GB. Hepatic sinusoidal obstruction following Gemtuzumab Ozogamicin (Mylotarg®). Blood 2002;99:2310-2314
42. Tornesello A, Piciacchia D, Mastrangelo S, Lasorella A, Mastrangelo R. Veno-occlusive disease of the liver in right-sided Wilms' tumours. Eur J Cancer 1998;34:1220-1223
43. Czauderna P, Katski K, Kowalczyk J, et al. Venoocclusive liver disease (VOD) as a complication of Wilms' tumour management in the series of consecutive 206 patients. Eur J Pediatr Surg 2000;10:300-303
44. Mattocks AR. Toxicity of pyrrolizidine alkaloids. Nature 1968;217:723-728
45. Lafranconi WM, Huxtable RJ. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Biochem Pharmacol 1984;33:2479-2484
46. Mattocks AR, White INH. The conversion of pyrrolizidine alkaloids to n-oxides and to dihydropyrrolizidine derivatives by rat-liver microsomes in vitro. Chem Biol Interact 1971;3:383-396
47. Hilliker KS, Garcia CM, Roth RA. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices. Res Commun Chem Pathol Pharmacol 1983;40:179-197
48. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venooclusive disease. Hepatology 1996;23:589-599
49. Hill DL. Microsomal metabolism of triazenylimidazoles. Cancer Res 1975;35:3106-3110
50. DeLeve LD. Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology 1996;24:830-837
51. Kachel DL, Martin WJ II. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. J Pharmacol Exp Ther 1994;268:42-46
52. Liano F, Moreno A, Teruel JL, Lamas S, Matesanz R, Ortuno J. Hepatic veno-occlusive disease and renal transplantation. [letter]. Ann Intern Med 1986;105:625-626
53. Lemley DE, DeLacy LM, Seeff LB, Ishak KG, Nashel DJ. Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis [see comments]. Ann Rheum Dis 1989;48:342-346
54. Kaplowitz N. Enzymatic thiolysis of azathioprine in vitro. Biochem Pharmacol 1976;25:2421-2426
55. Kaplowitz N, Kuhlenkamp JF. Inhibition of hepatic metabolism of azathioprine in vivo. Gastroenterology 1978;74:90-92
56. DeLeve LD, McCuskey RS, Wang X, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999;29:1779-1791
57. DeLeve LD, Ito I, Bethea NW, McCuskey MK, Wang X, McCuskey RS. Embolization by sinusoidal lining cell obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol 2003;284:G1045-G1052
58. DeLeve LD, Wang X, Tsai J, Kanel GC, Strasberg SM, Tokes ZA. Prevention of sinusoidal obstruction syndrome (hepatic venoocclusive disease) in the rat by matrix metalloproteinase inhibitors. Gastroenterology 2003;125:882-890
59. Lamé MW, Jones AD, Wilson DW, Dunston SK, Segall HJ. Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells. J Biol Chem 2000;275:29091-29099
60. Werb Z, Hembry RM, Murphy G, Aggeler J. Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol 1986;102:697-702
61. Allenberg M, Weinstein T, Li I, Silverman M. Activation of procollagenase IV by cytochalasin D and concanavalin A in cultured rat mesangial cells: linkage to cytoskeletal reorganization. J Am Soc Nephrol 1994;4:1760-1770
62. MacDougall JR, Kerbel RS. Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. Exp Cell Res 1995;218:508-515
63. DeLeve LD, Wang X, Kanel GC, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003;38:900-908
64. Harb R, Lutzko C, Guo Y, et al. Origin of sinusoidal endothelial cells (SEC) and role of SEC precursors in the outcome of hepatic sinusoidal obstruction syndrome (SOS/VOD). Gastroenterology 2005;128:A696
65. Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002;51:275-280
66. Ibarrola C, Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003;42:251-264
67. Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996;28:195-204
68. Shedlofsky S, Koehler RE, DeSchryver-Kecskemeti K, Alpers DH. Noncirrhotic nodular transformation of the liver with portal hypertension: clinical, angiographic, and pathological correlation. Gastroenterology 1980;79:938-943
69. Arvanitaki M, Adler M. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology 2001;48:1425-1429
70. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990;12:460-465
71. Grazioli L, Alberti D, Olivetti L, et al. Congenital absence of portal vein with nodular regenerative hyperplasia of the liver. Eur Radiol 2000;10:820-825
72. Vora A, Mitchell CD, Lennard L, et al. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 2006;368:1339-1348
73. Galdeano S, Drug R. Nodular regenerative hyperplasia of fetal liver: a report of two cases. Pediatr Pathol 1991;11:479-85
74. Iber FL. Obliterative portal venopathy of the liver and "idiopathic portal hypertension". Ann Intern Med 1969;71:660-661
75. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine 1980;59:367-379
76. Shimamatsu K, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997;26:343-350
77. Bioulac-Sage P, Dubuisson L, Bedin C, et al. Nodular regenerative hyperplasia in the rat induced by a selenium-enriched diet: study of a model. Hepatology 1992;16:418-425
78. Maione D, Di Carlo E, Li W, et al. Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 1998;17:5588-5597
79. Croquelois A, Blindenbacher A, Terracciano L, et al. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice. Hepatology 2005;41:487-496
80. McEntee MF, Wright KN, Wanless I, DeVovo R, Schneider JF, Shull R. Noncirrhotic portal hypertension and nodular regenerative hyperplasia of the liver in dogs with mucopolysaccharidosis type I. Hepatology 1998;28:385-390
81. Fonseca V, Havard CW. Portal hypertension secondary to azathioprine in myasthenia gravis. Postgrad Med J 1988;64:950-952
82. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994;20:88-94
83. Mion F, Napoleon B, Berger F, Chevallier M, Bonvoisin S, Descos L. Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis. Gut 1991;32:715-717
84. Russmann S, Zimmermann A, Krahenbuhl S, Kern B, Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001;13:287-290
85. Vora A, Mitchell CD, Lennard L, et al. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. [see comment]. Lancet 2006;368:1339-1348
86. Dubinsky MC, Vasiliauskas EA, Singh H, et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003;125:298-303
87. Snover DC, Weisdorf S, Bloomer J, McGlave P, Weisdorf D. Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 1989;9:443-448
88. Dubois A, Dauzat M, Pignodel C, et al. Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations. Hepatology 1993;17:246-250
89. Lorenz R, Brauer M, Classen M, Tornieporth N, Becker K. Idiopathic portal hypertension in a renal transplant patient after long-term azathioprine therapy. Clin Investig 1992;70:152-155
90. Tzirogiannis KN, Papadimas GK, Kondyli VG, et al. Peliosis hepatis: microscopic and macroscopic type, time pattern, and correlation with liver cell apoptosis in a model of toxic liver injury. Dig Dis Sci 2006;51:1998-2006
91. Leong SS, Cazen RA, Yu GS, LeFevre L, Carson JW. Abdominal visceral peliosis associated with bacillary angiomatosis. Ultrastructural evidence of endothelial destruction by bacilli. Arch Pathol Lab Med 1992;116:866-871
92. Scoazec JY, Marche C, Girard PM, et al. Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV). An ultrastructural study. Am J Pathol 1988;131:38-47
93. Goerdt S, Sorg C. Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders. Clin Investig 1992;70:89-98
94. Rose PG. Paracetamol overdose and liver damage. BMJ 1969;1:381-382
95. Thompson RPH, Clark R, Wilson RA, et al. Hepatic damage from overdose of paracetamol. Gut 1972;13:836
96. Zimmerman HJ. Effects of aspirin and acetaminophen on the liver. Arch Intern Med 1981;141:333-342
97. Klatskin G, Conn HO. Histopathology of the Liver. New York: Oxford University Press; 1993
98. Zimmerman HJ. Syndromes of environmental hepatotoxins. Hepatotoxicity- the adverse effect of drugs and other chemicals on the liver. New York: Appleton-Century-Crofts; 1978:279-302
99. Dixon MF, Nimmo J, Prescott LF. Experimental paracetamol-induced hepatic necrosis: a histopathological study. J Pathol 1971;103:225-229
100. Dixon MF, Dixon B, Aparicio SR, Loney DP. Experimental paracetamol-induced hepatic necrosis: a light- and electron-microscope, and histochemical study. J Pathol 1975;116:17-29
101. Miller DJ, Pichanick GG, Fiskerstrand C, Saunders S. Hepatic erythrocyte sequestration as a cause of acute anaemia. Am J Dig Dis 1977;22:1055-1059
102. Chiu S, Bhakthan NMG. Experimental acetaminophen-induced hepatic necrosis: biochemical and electron microscopic study of cyteamine protection. Lab Invest 1978;39:193-203
103. Walker RM, Massey TE, McElligott TF, Racz WJ. Acetaminophen-induced hypothermia, hepatic congestion, and modification by N-acetylcysteine in mice. Toxicol Appl Pharmacol 1981;59:500-507
104. Walker RM, Racz WJ, McElligott TF. Acetaminophen-induced hepatotoxic congestion in mice. Hepatology 1985;5:233-240
105. Walker RM, Racz WJ, McElligott TF. Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice. Am J Pathol 1983;113:321-330
106. Ito Y, Bethea NW, Abril ER, McCuskey RS. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation 2003;10:391-400
107. DeLeve LD, Wang X, Kaplowitz N, Shulman HM, Bart JA, van der Hoek A. Sinusoidal endothelial cells as a target for acetaminophen toxicity: direct action versus requirement for hepatocyte activation in different mouse strains. Biochem Pharmacol 1997;53:1339-1345
108. Liu J, Waalkes MP, Clark J, Myers P, Saavedra JE, Keefer LK. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology 2003;37:324-333
109. Ito Y, Abril ER, Bethea NW, McCuskey RS. Role of nitric oxide in hepatic microvascular injury elicited by acetaminophen in mice. Am J Physiol Gastrointest Liver Physiol 2004;286:G60-G67
110. Ito Y, Abril ER, Bethea NW, McCuskey RS. Inhibition of matrix metalloproteinases minimizes hepatic microvascular injury in response to acetaminophen in mice. Toxicol Sci 2005;83:190-196
111. Caldwell-Kenkel JC, Thurman RG, Lemasters JJ. Selective loss of nonparenchymal cell viability after cold ischemic storage of rat livers. Transplantation 1988;45:834-837
112. McKeown CMB, Edwards V, Phillips MJ, Harvey PRC, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 1988;46:178-191
113. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989;10:292-299
114. Imamura H, Brault A, Huet PM. Effects of extended cold preservation and transplantation on the rat liver microcirculation. Hepatology 1997;25:664-671
115. Aguilar HI, Steers JL, Wiesner RH, Krom RA, Gores GJ. Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allografts. Transplantation 1997;63:612-614
116. Kohli V, Gao W, Camargo CA Jr, Clavien PA. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc Natl Acad Sci U S A 1997;94:9354-9359
117. Upadhya AG, Topp SA, Hotchkiss RS, Anagli J, Strasberg SM. Effect of cold preservation on intracellular calcium concentration and calpain activity in rat sinusoidal endothelial cells. Hepatology 2003;37:313-323
118. Upadhya AG, Strasberg SM. Evidence that actin disassembly is a requirement for matrix metalloproteinase secretion by sinusoidal endothelial cells during cold preservation in the rat. Hepatology 1999;30:169-176
119. Upadhya AG, Harvey RP, Howard TK, Lowell JA, Shenoy S, Strasberg SM. Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology 1997;26:922-928
120. Cottart CH, Do L, Blanc MC, et al. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology 1999;29:809-813
121. Morisue A, Wakabayashi G, Shimazu M, et al. The role of nitric oxide after a short period of liver ischemia-reperfusion. J Surg Res 2003;109:101-109
122. Serracino-Inglott F, Virlos IT, Habib NA, Williamson RC, Mathie RT. Differential nitric oxide synthase expression during hepatic ischemia-reperfusion. Am J Surg 2003;185:589-595
123. Upadhya GA, Strasberg SM. Platelet adherence to isolated rat hepatic sinusoidal endothelial cells after cold preservation. Transplantation 2002;73:1764-1770
124. Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Synergism between platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic rat liver: a Kupffer cell-mediated injury. FASEB J 2001;15:1230-1232
125. Lasnier E, Blanc MC, Housset C, Rey C, Roch-Arveiller M, Vaubourdolle M. Cytotoxic response of sinusoidal endothelial cells to polymorphonuclear leukocytes and its potential implication in hypoxia-reoxygenation injury. Liver 2002;22:495-500
126. Man K, Lo CM, Ng IO, et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 2001;136:280-285
127. Man K, Fan ST, Lo CM, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003;237:256-264
128. Demetris AJ, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 2006;30:986-993